This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product, to the agency. The contract has a ceiling value of $4,624.40 and was awarded on December 10, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed price pricing type and an ultimate completion date of December 11, 2024. This award does not have a set-aside designation, indicating open competition. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/11/25, 9:42 AM